Kezar Life Sciences, Inc.

Historical 13F Holders

Symbol
KZR
CUSIP
49372L100
All holders as of
Q3 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 49372L100 since 12/18/2024, newest first.

Filer % of Class Filed
BML Investment Partners, L.P. 13G/A Amendment 3 0% 5/12/2026
Event 5/11/2026
BML Investment Partners, L.P. 13G/A Amendment 2 9.8% 2/9/2026
Event 12/31/2025
Barclays PLC 13G/A Amendment 2
Checked 5% or less
3/21/2025
Event 9/30/2024
BML Investment Partners, L.P. 13G 5.1% 3/6/2025
Event 2/28/2025
Equal Talent Investments Ltd 13D/A Amendment 5
8.7% 3/3/2025
Event 2/28/2025
Avidity Partners Management LP 13G/A Amendment 3
6.9%
Checked 5% or less
2/14/2025
Event 12/31/2024
Morningside Venture Investments Ltd 13D/A Amendment 4
8.5% 1/16/2025
Event 12/3/2024
Barclays PLC 13G/A Amendment 1 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q3 61 37.7 M $30.5 M
2024 Q2 85 39.4 M $23.6 M
2024 Q1 91 45.0 M $40.6 M
2023 Q4 88 50.1 M $47.5 M
2023 Q3 92 55.5 M $66.0 M
2023 Q2 114 56.9 M $139 M
2023 Q1 148 60.1 M $188 M
2022 Q4 130 61.7 M $434 M
2022 Q3 142 57.6 M $496 M
2022 Q2 144 54.9 M $454 M
2022 Q1 136 44.2 M $734 M
2021 Q4 118 40.5 M $676 M
2021 Q3 78 28.1 M $243 M
2021 Q2 76 27.6 M $150 M
2021 Q1 85 26.6 M $158 M
2020 Q4 81 23.6 M $123 M
2020 Q3 82 23.2 M $112 M
2020 Q2 90 23.2 M $120 M
2020 Q1 61 19.9 M $86.6 M
2019 Q4 57 9.30 M $37.3 M
2019 Q3 56 9.43 M $30.9 M
2019 Q2 55 10.0 M $77.2 M
2019 Q1 53 9.96 M $177 M
2018 Q4 42 9.40 M $222 M
2018 Q3 40 9.15 M $196 M
2018 Q2 27 8.16 M $141 M